Literature DB >> 29137865

Aminomethylation of heliomycin: Preparation and anticancer characterization of the first series of semi-synthetic derivatives.

Georgy Y Nadysev1, Alexander S Tikhomirov1, Ming-Hung Lin2, Ya-Ting Yang3, Lyubov G Dezhenkova4, Huei-Yu Chen3, Dmitry N Kaluzhny5, Dominique Schols6, Alexander A Shtil7, Andrey E Shchekotikhin8, Pin Ju Chueh9.   

Abstract

A series of 4-aminomethyl derivatives of heliomycin 1 was prepared using the Mannich reaction. The modification significantly improved aqueous solubility of the initially poorly soluble antibiotic. Testing the antiproliferative efficacy revealed a potent activity of heliomycin as well as its new derivatives on a panel of mammalian tumor cells including drug resistant variants. In contrast to 1 the new derivatives 7a, 7l, 7p generated a high level of ROS associated with induction of apoptosis in T24 bladder cancer cells. Introduction of 4-aminomethyl moiety increased the affinity to DNA and the ability to inhibit topoisomerase 1 making 7p the most promising candidate for further preclinical evaluation. Thus, aminomethylation is the first-in-class successful transformation of the antibiotic 1 resulting in an improved water solubility of derivatives and promising properties in search of novel anticancer drug candidates.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticancer agents; Apoptosis; DNA; Heliomycin; Mannich aminomethylation; ROS; Resistomycin

Mesh:

Substances:

Year:  2017        PMID: 29137865     DOI: 10.1016/j.ejmech.2017.10.055

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Antibiotic heliomycin and its water-soluble 4-aminomethylated derivative provoke cell death in T24 bladder cancer cells by targeting sirtuin 1 (SIRT1).

Authors:  Ming Hung Lin; Atikul Islam; Yen-Hui Liu; Chia-Wei Weng; Jun-Han Zhan; Ru-Hao Liang; Alexander S Tikhomirov; Andrey E Shchekotikhin; Pin Ju Chueh
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

2.  A Unique Prototypic Device for Radiation Therapy: The p53-Independent Antiproliferative Effect of Neutron Radiation.

Authors:  D I Yurkov; S V Syromukov; V V Tatarskiy; E S Ivanova; A I Khamidullina; M A Yastrebova; V I Sysoev; R V Dobrov; A V Belousov; V N Morozov; M A Kolyvanova; G A Krusanov; V I Zverev; A A Shtil
Journal:  Acta Naturae       Date:  2019 Jul-Sep       Impact factor: 1.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.